Boston Partners’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.4M Sell
1,017,683
-36,953
-4% -$1.21M 0.04% 287
2025
Q4
$32M Buy
1,054,636
+7,759
+0.7% +$220K 0.03% 318
2025
Q3
$26.9M Buy
1,046,877
+845,048
+419% +$20.1M 0.03% 339
2025
Q2
$4.23M Buy
+201,829
New +$4.55M ﹤0.01% 460

Other funds holding GRDN

Boston Partners's GRDN Position: Q1 2026 in Review

Boston Partners reduced its Guardian Pharmacy Services (GRDN) stake by 3.5% in Q1 2026, selling an estimated $1.21M and leaving 1,017,683 shares worth $38.4M. The position accounts for 0.04% of the portfolio, ranked #287.

Boston Partners first reported a position in GRDN in Q2 2025 and has held it in 4 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Boston Partners held 1,017,683 shares of Guardian Pharmacy Services worth $38.4M as of Q1 2026.
  • Boston Partners sold 36,953 Guardian Pharmacy Services shares in Q1 2026, an estimated $1.21M.
  • Guardian Pharmacy Services made up 0.04% of Boston Partners's portfolio in Q1 2026, its #287 holding.
  • Boston Partners first reported a position in Guardian Pharmacy Services in Q2 2025 and has held it in 4 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.